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ABSTRACT  The functional roles of the two nucleotide binding folds, NBF1  and NBF2,  in 
the activation of the cystic fibrosis transmembrane conductance regulator (CFTR) were inves- 
tigated by measuring the rates of activation and deactivation of CFTR CI- conductance in Xe- 
nopus oocytes. Activation  of wild-type  CFTR  in  response  to  application  of forskolin  and 
3-isobutyl-l-methylxanthine (IBMX) was described by a single exponential. Deactivation after 
washout of the cocktail consisted of two phases: an initial slow phase, described by a latency, 
and an exponential decline. Rate analysis  of CFTR variants bearing analogous mutations in 
NBF1 and NBF2 permitted us to characterize amino acid substitutions according to their ef- 
fects on the accessibility and stability of the active state.  Access to the active state was very sen- 
sitive  to substitutions for the invariant glycine (G551)  in NBF1, where mutations to alanine 
(A), serine  (S), or aspartic acid (D)  reduced the apparent on rate by more than tenfold. The 
analogous substitutions in NBF2 (G1349) also reduced the on rate, by twofold to 10-fold, but 
substantially destabilized the active state as well, as judged by increased deactivation rates. In 
the putative ATP-binding pocket of either NBF,  substitution  of alanine,  glutamine  (Q),  or 
arginine (R) for the invariant lysine  (K464 or K1250)  reduced the on rate similarly,  by two- to 
fourfold. In contrast, these analogous substitutions produced opposite effects on the deactiva- 
tion rate. NBF1 mutations destabilized the active state, whereas the analogous substitutions in 
NBF2 stabilized the active state such that activation was prolonged compared with that seen 
with  wild-type  CFTR.  Substitution  of asparagine  (N)  for a  highly conserved aspartic  acid 
(D572) in the ATP-binding pocket of NBF1 dramatically slowed the on rate and destabilized 
the active state. In contrast, the analogous substitution in NBF2 (D1370N) did not apprecia- 
bly affect the on rate and markedly stabilized the active state.  These results are consistent with 
a hypothesis for CFTR activation that invokes the binding and hydrolysis of ATP at NBF1 as a 
crucial step in activation, while at NBF2, ATP binding enhances access to the active state, but 
the rate of ATP hydrolysis controls the duration of the active state. The relatively slow time 
courses for activation and deactivation suggest that slow processes modulate ATP-dependent 
gating. 
INTRODUCTION 
The cystic fibrosis transmembrane conductance regula- 
tor (CFTR)  is a  membrane protein that functions as a 
Cl--selective ion channel  (Anderson et al.,  1991b; Bear 
et  al.,  1992).  Analysis  of the  primary  amino  acid  se- 
quence  of CFTR  (Riordan  et  al.,  1989)  provided evi- 
dence for three cytosolic domains that are likely to be 
involved in the regulation of CFTR function: the R do- 
main, which contains multiple consensus sites for phos- 
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phorylation by cAMP-dependent protein kinase  (PKA), 
and  two nucleotide  binding folds  (NBF1  and  NBF2), 
both containing regions with high sequence similarity 
to  a  family of proteins  known  to  bind  and  hydrolyze 
ATP.  This  predicted  domain  topology foreshadowed 
functional studies  of CFTR demonstrating that activa- 
tion of CFTR C1- channels requires phosphorylation at 
one or more sites as well as the binding and hydrolysis 
of ATP  (Anderson  et  al.,  1991a;  Berger  et  al.,  1991; 
Cheng et al.,  1991; Tabcharani et al.,  1991; Bear et al., 
1992; Carson and Welsh,  1993; Baukrowitz et al.,  1994; 
Hwang et al., 1994). 
The  two  NBFs  of CKI'R exhibit  sequence  similarity 
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residues in the two domains (Riordan et al., 1989; Gre- 
gory  et  al.,  1991).  In  a  previous  study  (Smit  et  al., 
1993), we compared the effects of analogous mutations 
in NBF1 and NBF2 on the steady state activation kinet- 
ics of CFTR, assayed by determining the dose-response 
for the  activation of cAMP-dependent C1-  currents by 
the  phosphodiesterase  inhibitor, IBMX,  in  the  pres- 
ence of forskolin, an activator of adenylate cyclase. The 
results suggested that both NBFs function in the activa- 
tion of CFTR, but in different ways. Mutations of an in- 
variant  glycine  in  either  NBF1  (G551)  or  NBF2 
(G1349)  produced similar reductions in the sensitivity 
to  activating conditions. In contrast, mutations in the 
putative  ATP-binding pockets  of  the  two  NBFs  pro- 
duced  opposite  results,  a  reduction  in  sensitivity for 
mutations in NBF1  (K464Q, D572N) and an increase in 
sensitivity  for  the  analogous  mutations  in  NBF2 
(K12500~ D1370N). 
In the  studies described here,  we  characterized the 
roles  of the  two  NBFs  in the  opening and closing of 
CFTR C1  channels by measuring the rates of activation 
and  deactivation of  C1-  conductance associated  with 
wild-type CFFR and mutants bearing single amino acid 
substitutions in NBF1 or NBF2. Using a two-state model 
for activation, we  examined the  roles of each  NBF in 
regulating access to the activated state  (on rate)  and in 
determining  the  stability  of  the  activated  state  (off 
rate).  The  results  are  compatible  with  a  scheme  in 
which  the  two  NBFs  interact  to  effect  activation  of 
CFTR in a manner such that ATP binding and hydroly- 
sis at NBF1  is critical for entering the  active state, but 
ATP binding at NBF2 also contributes to this process. 
Both  NBFs appear to influence the stability of the ac- 
tive  state,  but in  opposite  ways,  NBF1  stabilizing and 
NBF2  destabilizing  the  conducting  conformation. 
Some of this work has been presented in abstract form 
(Wilkinson et al., 1993, 1994). 
MATERIALS  AND  METHODS 
Site-directed Mutagenesis,  Plasmid Construction, 
and RNA Synthesis 
CFTR mutants were  generated as described previously  (Smit et 
al., 1993) by cloning Sph I-Sac I fragments of the CFTR cDNA 
into the pSelect vector (Promega Corp.,  Madison, WI) and per- 
forming site-directed mutagenesis, using oligonucleotides that 
corresponded to the desired mutations. A 1.7-kb fragment of the 
cDNA that includes the Walker A region of NBF1 was used to 
make mutations at lysine 464, while  a 3.0-kb fragment that in- 
cludes glycine 551  and the Walker B region of NBF1 as well as 
glycine 1349 and the Walker A and B regions of NBF2 was used to 
make  mutations at  those  sites. Mutations were  verified by se- 
quencing, and the  mutated fragments were  transferred into a 
full-length CFTR cDNA construct (Drumm et al., 1990) in pBlue- 
script (Stratagene Inc., LaJolla, CA), RNA was synthesized  by in 
vitro transcription, as described previously (Drumm et al., 1991), 
then suspended in diethylpyrocarbonate-treated water for injec- 
tion. 
Oocytes and RNA Injection 
Female toads  (Xenopus laevis, Xenopus-I, Inc., Ann Arbor, MI) 
were  anesthetized by immersion in ice water containing 3-ami- 
nobenzoic acid ethyl ester (Tricaine, 3 mg/ml, Sigma Chemical 
Co., St. Louis, MO), and oocytes were removed through a small 
abdominal incision. The follicular membranes were removed by 
blunt dissection after incubation for 2-6 h in a nominally Ca  2+- 
free denuding solution containing 82.5 mM NaC1, 2 mM KC1, 1 
mM MgCI~, 5 mM HEPES (pH 7.5), and 2.5 mg/ml collagenase 
(Gibco Laboratories, Grand Island, NY). Defolliculated oocytes 
were kept overnight in a modified Barth's solution (MBSH) con- 
mining 88 mM NaC1, 1 mM KC1, 2.4  mM NaHCO~, 0.82  mM 
MgSO4, 0.33 mM Ca(NO3)2, 0.41 mM CaC12, 10 mM HEPES, and 
gentamicin sulfate  (150 mg/liter), then injected with 0.1-15 ng 
of RNA (50 nl volume) using a microinjector (Drummond Scien- 
tific  Co.,  Broomhall, PA).  Injected oocytes  were  incubated at 
19~  in 96-well microtiter plates containing MBSH, with one oo- 
cyte  per well. Injection pipettes were  pulled from  glass tubes 
(Drummond Scientific  Co.),  and the tips were beveled to mini- 
mize damage to the oocytes during injection. The internal sur- 
face  of each pipette was neutralized by dipping the  unbeveled 
end in a siliconizing agent (Sigmacoate,  Sigma  Chemical Co.) 
and baking the pipettes, tips up, at 200~  for at least 1 h. 
Electrophysiology and Experimental Protocol 
Oocytes injected 3-6 d previously were perfused individually  with 
an amphibian Ringer's solution containing 100.5 mM Na  +, 2 mM 
K  +, 1.8 mM Ca  ~+, 1 mM Mg  2§  105.6 mM (11  , and 5 mM HEPES 
(pH 7.5). Each oocyte was impaled with two microelectrodes, the 
membrane potential  (V,10 was  clamped using a  two-electrode 
voltage clamp (TEV-200, Dagan Instruments, Minneapolis, MN), 
and membrane currents (/m) were measured. The value of/,,, at a 
holding potential of -60 mV was monitored continuously on a 
chart recorder. The membrane conductance (g) at -60 mV was 
determined by stepping  V,,, from  -60  mV to  -120 mV,  then 
clamping V,n to voltages between -120 and +40 mV using a com- 
puter-driven ramp command (Clampex,  Axon Instrnments Inc., 
Foster City, CA) that changed the voltage at a rate of 100 mV/s. 
The l-Vrelationship  was constructed from the digitized values of 
/,,, and V,,,, and the conductance at -60 mV was calculated from 
the slope of the 1-Vrelationship between -70 and -50 inV. 
The time course for activation of CFTR (11- conductance was 
determined by changing the oocyte perfnsate to a Ringer's solu- 
tion  that  contained  10  ~M  forskolin  and  5  mM  3-isobutyl-1- 
methylxanthine (IBMX).  Forskolin (Research  Biochemicals  In- 
ternational, Natick, MA or Sigma Chemical Co.) was added from 
a 20-raM stock  in ethanol and IBMX (RB1 or Sigma Chemical 
Co.) was added from a 500-raM stock in dimethylsulfoxide. In tin- 
injected or water-injected oocytes, the membrane conductance at 
-60 mV was not affected  by the cocktail of forskolin and IBMX, 
but in oocytes  expressing CFTR, a  time-dependent increase in 
membrane conductance was elicited (see Drumm et  al.,  1991). 
The maximum possible concentration of IBMX (5 raM) was cho- 
sen to maximize the activation  rate of cAMP-dependent protein 
kinase and to optimize the activation level of insensitive CFTR 
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conditions. The  time  course  for activation was determined by 
measuring  the  conductance  periodically  until  no  further  in- 
crease was discernible, indicating the establishment of an  acti- 
vated steady state. The CFTR C1- conductance activated at any 
time after addition of forskolin and IBMX, gel(t), was calculated 
by  subtracting  the  background  conductance  measured before 
the addition of the drugs. To account for variability in the activa- 
tion rates caused by differences in the level of CYI'R expression 
among oocytes, the values of gcl(t)  were normalized to the maxi- 
mum  conductance, gel(max),  measured in  the  activated steady 
state. 
The activation of CFTR C1-  conductance was described over 
most of its time course by a single exponential, as illustrated for 
wild type CFTR in Fig. 1. The activation rate was quantified by fit- 
ring a single exponential function to the data points between 15 
and 85%  of maximal activation. This range effectively excluded 
very early times, during which activation of the cytosolic enzymes 
was likely to be rate limiting, and very late times, when the rate of 
rise was slow and more difficult to quantify. 
To examine the kinetics of CFTR deactivation, we monitored 
the time course for deactivation of CFI'R C1  conductance after 
washout of forskolin and IBMX from the perfusate. Membrane 
conductance was measured in the activated steady state and peri- 
odically after changing the perfusate back to normal Ringer's so- 
lution,  until  no  further change was discernible. The  activated 
CFTR  conductance  remaining  at  any  time  after  the  solution 
change  (time 0)  was estimated by subtracting the value  of the 
minimum membrane conductance measured in the deactivated 
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FIGURE  1.  Representative time course for activation of wild-type 
CFTR expressed in Xenopus oocytes. CFTR C1- conductance (gc0 
was determined periodically after addition  (at time 0)  of 10  IxM 
forskolin and 5 mM IBMX to the oocyte perfusate. The measured 
values, gel(t), are plotted as a percentage of the maximum value, 
gel(max), measured in  the activated steady state.  In  this experi- 
ment, the value of gel(max ) was 23.4 t~S and the background mem- 
brane conductance before stimulation was 1.9 I~S. The inset shows 
the  normalized  conductance  values  between  15  and  85%  of 
gel(max)  plotted on a  natural logarithmic scale, for estimation of 
(ko,  +  k~,ft) according to Eq.  1.  From the linear regression (solid 
line),  the value of (k~,,, +  koft-) was 0.866 min  -1 with a regression co- 
efficient (r  2) of 0.992. 
steady state. These values were then normalized to the maximum 
value of gel observed during the deactivation time course. 
The deactivation of CFTR C1- conductance was more complex 
than  activation,  as  illustrated  in  Fig.  2.  Representative  time 
courses are shown for wild type CFTR and two variants, K464Q 
and K1250Q. The former exhibits reduced steady state sensitivity 
to  activation,  whereas  the  latter  exhibits  increased  sensitivity 
(Smit et al.,  1993).  The characteristic time course for deactiva- 
tion of wild-type CFTR was a transient increase in gcl followed by 
a  decline toward baseline. We interpreted the increase in gel as 
the relief of IBMX block of CFTR, which has been documented 
in studies of single CFTR channels (Richards, Marth, and Daw- 
son, unpublished observations; Schultz et al.,  1994).  The  tran- 
sient increase in gel was most evident for wild-type CFTR and mu- 
tants such as K1250Q, which remained fully activated for several 
minutes after washout of IBMX. In contrast, the decline in gel for 
mutants such as K464Q was rapid, showing only a slight increase 
after IBMX withdrawal.  In  view of this  transient behavior, we 
chose to characterize the rate of deactivation in terms of two pa- 
rameters: (a)  the latency between drug removal (time 0) and de- 
activation to 85% of maximum gcl, and (b) the rate of decline be- 
tween 85 and 15% of maximum gcl- For wild-type CFTR, the sec- 
ond component appeared to consist of two phases, an initial slow 
decline followed by a faster decline, but for comparison this was 
approximated by a single exponential decay because for all of the 
CFTR mutants examined here, the second component was well 
described by a single exponential (Fig. 2). 
Interpretation  of Activation  and Deactivation  Rates 
In view of the fact that the rates of activation for wild-type and the 
mutant CFTRs examined here were dominated by single expo- 
nential time courses, we interpreted the rate of approach to the 
steady state  gel  in  terms of a  model  that  recognizes only  two 
states, inactive (I) and active (A). 
kon 
I\  \A. 
k,, f~ 
In this scheme, k,,. represents the lumped rate coefficient for re- 
actions and conformational changes that contribute to establish- 
ing the active state, and ko~ represents the lumped rate coeffi- 
cient for the reactions and conformational changes involved in 
the return to the inactive state. The coefficient ko~- is a measure 
of the stability of the activated state under activating conditions 
and should be distinguished from the off rate that was measured 
following removal of the activating stimulus. We designate this 
latter parameter as *ko,-, which is a measure of the stability of the 
active state in the absence of activating conditions (see below). 
For the two-state model, the rate of approach of gel to steady 
state activation is described by 
gcl(t)  =  gel(max)  ￿9 (1-exp[-(kon+  ko,)t]),  (1) 
and the value of (k,,, +  kofr) is given by the slope ofa semiloga- 
rithmic plot of 1 -  gcl(t)/gc~(max)  vs t. The values of ko, and kott 
that characterize the approach to steady state activation can be 
calculated if the apparent Kl/2 for steady state activation  (KA) is 
known. The dose-dependent, steady state activation of CFTR by 
IBMX can be described by a single rectangular hyperbola. In pre- 
vious studies  (Drumm  et al.,  1991;  Snfit et  al.,  1993),  we  esti- 
mated the apparent KA for dose-dependent  activation from loga- 
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FmURE  2.  (A)  Representative  time  courses 
for  deactivation  of wild  type  CFTR  (0)  and 
the analogous lysine to glutamine  mutants in 
NBF1  (K464Q,  A)  and  NBF2  (K1250Q,  ~). 
CFI'R CI-  conductance  (g~:l) was determined 
periodically  after  removal  of  forskolin  and 
IBMX  from  the  oocyte  perfusate.  The  mea- 
sured values, gel (t), are plotted as a percentage 
of the  maxinmm  value,  gel(max),  measured 
during  deactivation.  In  the  experiments 
shown,  the  values  of gel(max)  for  wild-type 
CFTR,  K464Q,  and  K1250Q were  27.9,  36.3, 
and 30.3 I,S, and the corresponding minimum 
membrane conductances alter deactivation of 
CFTR were  2.1,  0.7,  and  1.0  ~S,  respectively. 
Deactivation  time  courses were characterized 
by two components: (a)  a latency period, dur- 
ing which gel increased transiently to gel(max) 
then  decreased to  85%  of gel(max),  followed 
by (b) a further deactivation that was approxi- 
mated by a single exponential. (B) Normalized 
conductance values between 85% and 15% of 
gcl(max)  are plotted on a  natural  logarithmic 
scale for estimations of *k,,t  t according to Eq. 7. For wild-type (0), K464Q (A), and KI250Q  (~),  the values of *k,,a determined from linear 
regressions (lines) were 0.134, 0.166, and 0.019 rain -l, and the corresponding regression coefficients (r  e) were 0.957, 0.999, and 0.998, re- 
spectively. 
rithmic dose-response plots, but for comparison with rates of ac- 
tivation we sought a  more unbiased estimate of Ka that took into 
account  three factors:  (1)  the activation  produced by forskolin 
alone,  (2)  the block of CFTR by high  concentrations of IBMX, 
and  (3)  the  fact  that  for  insensitive  mutants  such  as  G551D, 
D572N,  and G1349D  the dose-response showed no tendency to- 
ward saturation  at the highest concentrations of IBMX. Accord- 
ingly, we assumed that if the steady state dose-response data were 
corrected  for  the  small  response  in  the  presence  of forskolin 
alone,  then  the  activated gcJ would be  the  sun]  of two  compo- 
nents, one caused by activation of CFTR by IBMX and a  second 
caused by blockade of activated CFTR by IBMX: 
gc.lg'~':~t  '~  =  ( g"'l,~""￿  ￿9 [IBMX]/ 
k---  )  (2) 
where ghl/~ 'x  is the ratio  of the steady state conductance acti- 
vated  by a  particular  concentration  of [BMX  to  the  maximum 
IBMX-activated  conductance  actually  observed in  the  same  ex- 
periment, ~'~  is the hypothetical maximum gel that would be oh- 
stowed at maximum activation of CFTR in  the absence of block, 
and K~ and K I are the values of Kwz tbr activation and block, re- 
spectively. The block of CFTR by IBMX was assumed to represent 
a  unimolecular  binding  event.  Single-channel  records  suggest 
that the kinetics of block are fast, reducing the apparent ampli- 
tude of single-channel currents (Richards et al., unpublished ob- 
servations; Schultz et al.,  1994).  We assumed that the maximum 
blockable  conductance  was  equal  to  the  maxinmm  activatable 
conductance and that the value of K I was the same for all of the 
CFTR variants examined. 
The Kj fbr IBMX block was estimated from the response of the 
hypersensitive mutant, K1250A. Because K1250A is maximally ac- 
tivated at an IBMX concentration of,'-,1 raM, the block by higher 
concentrations of IBMX is readily apparent. The continuous curve 
in Fig. 3 A shows the fit of Eq. 2 to the dose-response data. Non- 
linear regression yielded values of ~'~1/~x  =  1. l 7 -4- 0.03 and Ki = 
9.5  _+  1.4 mM. Values of Kx for wild type and all of the mutants 
were obtained by assuming that the value of KI tor IBMX block 
was 9.5 raM. Eq. 2 was fit to the data from individual experiments 
to provide the most unbiased estimate of the variance in K  a. 
The value of N'!I/N'~I ~  estimated for the mutant K1250A indi- 
cated that  the maximum  gcJ actually observed,  g~'!i  ~'X, was  nearly 
equal  to  the maximum  possible activation,  N'~l,  presumably be- 
cause this conductance is achieved at an IBMX concentration of 
1 raM, where block is minimal. The calculated curves for activa- 
tion and block of K1250A are shown in Fig. 3 A, where the values 
of gel are normalized to the theoretical maximum, N'!].  For this 
mutant,  the two components of the dose-response to IBMX are 
well  separated  such  that  at  concentrations  of IBMX  below ~1 
mM the activation of CFTR predominates, whereas at higher con- 
centrations the conductance is progressively attenuated by 1BMX 
block. The magnitude of the transient increase in gel tor K1250A 
after removal of 5  mM IBMX in the rate experiments  (cf. Fig. 5 
B)  was consistent with this interpretation.  The peak value of get 
measured during the deactiw~tion time course was ~35% greater 
than the vahm measured in the presence of 5 mM IBMX, as pre- 
dicted for a Ki of 9.5 mM. 
For wild-wpe CFTR and the mutant K464Q,  the observed val- 
ues of ~'!i  '￿  were ~60% and 27% of the theoretical maximum g'cl, 
respectively. For these CFTR variants,  the activated ,g{:l does not 
approach  the  theoretical  maximum  conductance  for  two  rea- 
sons:  (a)  the values of K  a  are higher, so the activated get is pro- 
portionately  lower  at  any  concentration  of IBMX,  and  (b)  the 
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FIGURE 3.  The  IBMX  dose-response  relation- 
ships  for  steady  state  activation  and  block  of 
CFTR. Values of gcl were measured  in the pres- 
ence of 10  I~M forskolin alone and  in combina- 
tion with progressively increasing concentrations 
of  IBMX.  Dose-response  relations  were  deter- 
mined by subtracting the forskolin-stimulated gcl 
and  normalizing  the values of IBMX-stimulated 
gel to the maximum value, g'~  , measured in the 
same  oocyte.  The  fit of Eq.  2  to  the  combined 
data  for  the  hypersensitive  mutant  K1250A 
yielded a value of K  1  for the block by IBMX, as de- 
scribed in the text. (A) The plotted points (O) are 
means  -+ SEM for 10 oocytes expressing the mutant K1250A.  The measured values of gel are shown normalized to the theoretical maxi- 
mum, g~q. The continuous curve shows the fit of Eq. 2, and the dashed and dotted curves show, respectively, the components of activation 
(KA =  0.07 mM) and block (Kl =  9.5 mM).  (B) IBMX dose-response relations for steady state activation of K1250A (~), wild-type CFTR 
(Q, n =  26), and K464Q (A, n =  5). The data points were corrected for block using/~ =  9.5 mM. The continuous curves show the activa- 
tion predicted by the values Of KA, which were 0.07, 0.65, and 3.3 mM, respectively. 
block by IBMX becomes appreciable above 1 raM. In Fig. 3 B, the 
activation  components  for  wild-type  CFTR  and  the  mutants 
K1250A and K464Q were simulated by adding back the blocked 
component and plotting the adjusted data points along with the 
curves calculated using the estimated KA values. 
In view of the hyperbolic dose-response for steady state activa- 
tion  (Fig. 3/3)  and the first-order kinetics of activation  (Fig.  1), 
we assumed that the ko, for CFTR activation could be expressed 
as the product of the IBMX concentration and a lumped, pseudo 
first-order rate coefficient, k'o~, where 
kon  =  k'on[IBMX]  ,  (3) 
and the value of K  A  for steady state activation is given by 
K A =  kofflk'o,.  (4) 
Using  these  relations,  values for  k',,.  and  ko~ in  the  activated 
steady state  (5 mM IBMX) can be calculated from the measured 
values of (ko. + k,,fO: 
k'on  =  (kon +  kon.)/([IBMX]  + KA)  (5) 
and 
k,ff  =  (kon+  kotf)/(1  +  [IBMX]/KA)  .  (6) 
As  indicated  previously,  the  rate  of deactivation  of g(a  after 
abrupt removal of the activating conditions was complex and was 
described  by  two  empirical  parameters,  a  latency  to  85%  of 
(g~;i)  .... and an exponential decline given by 
gr  (t)  =  gt:l (max)  ￿9 exp [-*k,,fft]  ,  (7) 
where ga(max)  is the peak value of gcl during washout of IBMX 
and forskolin, and *k,,~ is the exponential off rate following the 
initial transient in gel(t). The values of *k,,~ tended to be greater 
than  the corresponding estimates of kofr, the calculated off rate 
under activating conditions, as expected if some feature of these 
conditions  reduced  the  deactivation  rate.  For  example,  IBMX 
may  inhibit  phosphatase  activity,  as  suggested  by  the  work  of 
Becq et al.  (1993),  and/or  IBMX itself may stabilize the active 
state  of CFTR (Schuhz  et al.,  1994).  Generally, however, muta- 
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tions induced qualitatively similar changes in ko, and *koff, sug- 
gesting that these two independent measures provide similar im- 
pressions of changes in the stability of the active state of CFTR. 
Statistical Comparisons 
The values of K, and the rate analysis parameters  for each mu- 
tam were compared with those for wild-type CFTR and with those 
for  other  mutants  using  a  one-way  analysis  of  variance  and 
Fisher's post hoc test of least significant differences. Analysis of 
variance is most appropriate if the variance is constant across in- 
dividual groups, but in the present case the variance tended to be 
proportional  to  the  magnitude  of the  parameter  in  question. 
Therefore, the variance for each parameter was stabilized before 
statistical analysis by taking the logarithm of all values (Snedecor 
and Cochran, 1967). 
RESULTS 
Mutations  in the Nucleotide Binding Folds Dramatically 
Altered the Rates of Activation  and Deactivation  of CFTR 
The  rate of activation of CFTR in oocytes is determined 
by  the  properties  of  a  multistep  reaction,  which  in- 
volves not only the dynamics of CFTR itself but also the 
properties  of cellular enzyme systems governing  the ac- 
tivities  of protein  kinases  and  phosphatases.  To  mini- 
mize the time required  for elevation of cytosolic cAMP 
and  protein  kinase A  activity, we used forskolin and the 
maximum  possible  concentration  of  the  phosphodi- 
esterase  inhibitor,  IBMX.  Mutations  in  CFTR  can  be 
reasonably  expected  to affect the  response  of CFTR to 
activating conditions,  but  not  the  dynamics  of cellular 
enzyme  systems.  In  the  course  of this  study,  we  found 
that  NBF  mutations  associated  with  altered  values  for 
the  (KA)mMX  caused  dramatic  changes  in  the  macro- 
scopic  kinetic  parameters  measured  here.  The  values 
listed in Table I  show that NBF mutations  generally re- 
duced  the value of (ko,,  +  ko~),  in  some  cases  by more TABLE  I 
Summary of  Activation and Deactivation Data for Wild-type CFFR and Mutants of the Invariant Glycine in NBFI ((;,551) or NBF2 (G1349) 
CFTR 
Activation  Deactivation 
klon 
KA  (k,,n + k,,n)  (10 ~  miu  -1  k,,n  kos  latency  *k,,t~ 
(raM)  n  (10 -~ min l)  raM-l)  (10 -3 min 1)  (10  ~  rain  -j)  n  (min)  (10  -s min  -I) 
wt  0.65 + 0.08  26  664 _+ 51  118 _+ 9  588 +- 45  76 + 6  20  6.0 _+ 0.3  88 -+ 6  16 
G551A  3.0 -+ 0.5*r  6  104 _+ 5"r  13 _+ 0.6*r  65 + 3*z  39 -+ 2*  5  7.7 +_ 0.5:  70 -+ 13:  4 
G551S  4.7 +- 0.5*  5  82 _+ 6*r  8 -+ 0.6*:  42 -+ 3*:  40 -+ 3*r  10  3.9 +_ 0.3***  88 +- 6:  6 
G551D  9.3 -+ 0.01"  6  57 _+ 9*r  4 -+ 0.6*:  20 -+ 3*:  37 -+ 6"r  5  1.8 _+ 0.2"~  84 -+ 10~  6 
G1349A  1.1 + 0.07*:  5  210 _+ 24"~  35 -+ 4*:  172 -+ 20*:  38 +- 4*  4  1.7 _+ 0.3"~  184 + 20*:  5 
G1349S  3.5 +- 0.3*  4  199 _+ 46*:  23 -+ 5*:  117 -+ 27*r  82 -+ 19+  6  2.3 _+ 0.5*+  144 -+ 15":  6 
G1349D  9.3 + 0.01"  8  114 _+ 16  *++  8 -+ 1":  40 +- 6*r  74 -+ 11~  5  0.6 -+ 0.1 *++  286 -+ 37*:  4 
Values were determined as described in Methods. The symbols (*) and (~) indicate significant  differences from wild-type  CFFR  and the analogous  mu- 
tant, respectively  (P < 0.05). 
than  10-fold. Likewise, values for the  latency and *ko~ 
were markedly mutant dependent, the former decreas- 
ing by as much as  10-fold or increasing by as much as 
3.7-fold compared with the wild type. Such changes are 
consistent with the  notion that the  rates  of activation 
and deactivation measured here reflect the kinetics of 
the  conversion of CFTR from an inactive to  an active 
state. Using the values Of KA and (kon +  koff) listed in Ta- 
ble I, it is possible to calculate values for the apparent 
kon  (or k'on) and koff that characterize the approach to 
steady state  activation. For wild-type CFTR,  for  exam- 
ple,  ko,i =  0.588  +-  0.045 min  -1  (k'on =  0.118  +  0.009 
min  -1 mM -l) and koff =  0.076  +  0.006 min  -1, suggest- 
ing  that,  at  5 mM  IBMX,  the  rate  of relaxation was 
dominated by the  on rate,  as  expected.  A  strict inter- 
pretation of these rates in terms of a  two-state, closed- 
open  channel-gating  process  would  require  closed 
times of the order of 1.7 min and open times of :'-'13 
min. The gating of CFTR C1- channels in cell-attached 
membrane  patches  has  not been  studied  extensively, 
but there is no suggestion in the available data for open 
and closed times of this magnitude. This suggests that 
there is a slow component to the dynamics of CFTR ac- 
tivation that is reflected in the  rates determined here 
(see  Discussion).  In  addition,  however,  it  is  possible 
that the activation rate may be artifactually reduced by 
the finite rate  of rise of intracellular PKA activity. De- 
spite  this possible attenuation, the  relative changes in 
kinetic  parameters  associated  with  NBF  mutations 
provide  an  approach  to  characterizing the  mutation- 
induced changes in accessibility or stability of the active 
state. 
Our  mutational analysis focused  on  three  residues 
that can be identified unambiguously in the two NBFs 
because of their locations within primary sequence mo- 
tifs  either  in ATPases  generally or  specifically within 
the  family of traffic ATPases.  In each  NBF, we  substi- 
tuted the invariant glycine (G551 in NBF1 or G1349 in 
NBF2), which lies in a  region that is characteristic  of 
traffic ATPases (Hyde et al., 1990; Mimura et al., 1991), 
is  invariant among  CF-FRs  of  different  species  (Dia- 
mond  et al.,  1991; Tucker et al.,  1992),  and is associ- 
ated with mutations that cause cystic fibrosis  (Cutting 
et al., 1990; Kerem et al., 1990; Strong et al., 1991). The 
other two sites lie within primary sequence motifs that 
form part of the nucleotide binding pocket in ATPases 
and GTPases for which crystal structures are  available 
(see  Discussion).  The  Walker  consensus  A  motif 
(Walker et al.,  1982)  forms a  glycine-rich, phosphate- 
binding loop in the hydrolytic core of ATPases and GT- 
Pases, and the invariant lysine near the carboxyl end of 
this motif participates in the binding and hydrolysis of 
ATP through associations with the [3- and ~-phosphates 
of ATP. The Walker consensus B  motif (Walker et al., 
1982) is also located within the phosphate-binding  por- 
tion of the  binding pocket,  and the  highly conserved 
aspartic acid at the carboxyl end of this motif may also 
participate  in ATP  hydrolysis.  In  Results  and  Discus- 
sion, we  refer  to  the  invariant glycine in  relation  to 
G551 in NBF1 or G1349 in NBF2 and to the ATP-bind- 
ing  pocket  in  reference  to  the  Walker  consensus A 
lysines (K464 in NBF1 and K1250 in NBF2) or the con- 
sensus B  aspartic  acids  (D572  in NBF1  and D1370  in 
NBF2). Although there is presently no definitive struc- 
tural information for either NBF of CFTR, this nomen- 
clature is useful for presenting the results of mutations 
at these sites. 
Steady State Activation of NBF Mutant C~7"Rs 
The values of KA obtained by curve fitting (Table I) are 
in accord with the qualitative analysis presented previ- 
ously (Smitet al.,  1993). The values of KA determined 
for  the  mutant CFTRs  all  differed  significantly from 
that of wild-type CFTR (P <  0.05). Substitutions for the 
invariant glycine in  either  NBF  produced  similar in- 
creases in KA, with the exception of the mutation that 
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nine  for glycine, which  in NBF1  (G551A)  produced a 
nearly fivefold increase  in  KA but in  NBF2  (G1349A) 
produced less than a twofold increase. In contrast, sub- 
stitutions  for  conserved  residues  in  the  putative ATP 
binding pocket produced opposing effects on KA. Sub- 
stitutions  in  NBF1  increased  KA from fourfold  to  14- 
fold  over that seen with wild-type CFrR,  whereas  the 
comparable  substitutions  in  NBF2  decreased  KA  by 
fourfold  to  ninefold.  These  differential  shifts  in  KA 
were an initial indication that NBF1 and NBF2 play dif- 
ferent roles in the activation of CFTR. 
Rate Analysis of Invariant Glycine Mutants 
Substitutions  for the  invariant glycine in  either NBF1 
(G551)  or NBF2  (G1349)  significantly slowed the rate 
of approach to steady state activation  (kon +  kofr) coin- 
pared  with  wild-type  CFTR,  and  the  reductions  pro- 
duced  by  the  substitutions  in  NBF1  were  more  pro- 
found than those produced by the analogous substitu- 
tions  in  NBF2  (P  <  0.05).  The  reductions  in  the 
relaxation rates can be seen clearly in  the  representa- 
tive traces shown in Fig. 4 A and in the values of (kon + 
kofr) listed in Table I. In NBF1,  substitution  to alanine 
(G551A),  the  most  conservative  change  possible,  re- 
duced the relaxation rate by more than sixfold, and the 
less conservative substitutions to serine (G551S) and as- 
partic  acid  (G551D)  progressively reduced  the  relax- 
ation rate. At the analogous site in NBF2, the most con- 
servative substitution  (G1349A)  also reduced the relax- 
ation rate, but by only about threefold. Substitutions to 
serine  (G1349S)  and aspartic acid (G1349D)  produced 
progressive reductions such that the relaxation rate for 
the  least  conservative  mutation,  G1349D,  was  about 
twice that for the comparable mutation in NBF1. 
The values of (ko,, +  korf) observed with the analogous 
mutations  in  NBF1  and  NBF2  suggested  that  the  ob- 
served increases in KA (koJk'o,)  arose primarily from a 
decrease in the  on rate. This impression is confirmed 
by an examination of the values calculated for the ap- 
parent  k'on  and  kofr, which  are  shown  in  Table  I  and 
compared in Fig. 5. Substitutions for G551 in NBF1 re- 
duced  the  on  rate  more  dramatically  than  the  analo- 
gous substitutions  for G1349 in NBF2.  In NBF1,  these 
substitutions  reduced  the on rate by 9- to 30-fold and 
slightly reduced the apparent off rate under activating 
conditions  (kotf), suggesting that the increase in K  A was 
due to a reduction in the accessibility of the active state 
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FIGURE 4.  Representative  time courses for acti- 
vation of CFTR mutants with substitutions of anal- 
ogous  amino acids in  NBF1 (solid symbols) and 
NBF2  (open symbols). Analogous  mutations  are 
designated  within  each panel by symbols of the 
same shape.  The representative  time course  for 
wild-type CFTR (Fig. 1) is replotted in each panel 
for reference (solid line). (A) Substitutions of the 
invariant  glycine  in  NBF1 (G551)  or  NBF2 
(G1349) by serine  (S, O, ￿9  or aspartic acid  (D, 
I, [~). (B) Substitutions of the Walker consensus 
A  lysine in  the  ATP  binding  pocket of NBFI 
(K464) or NBU2 (K1250) by alanine  (A, O, O) or 
glutamine  (Q,  I,  []).  Note  the  different  time 
scale.  (C)  Substitutions  of asparagine  for  the 
Walker consensus B aspartic acid in the ATP-bind- 
ing  pocket  of  NBFI (D572N, 0)  or  NBF2 
(D1370N, 0). 
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FIGURE 5.  Summary of mutation-induced effects on the activa- 
tion parameters.  Values for the pseudo-first-order on-rate coeffi- 
cient (k',,,) and for the off-rate coefficient (k,,a) were calculated us- 
ing the measured values of (k,,n +  k,,l,) and the corresponding esti- 
mates of Kx (Eqs. 5 and 6). Points are means +_ SEM for the ratios 
of the mutant values to the mean wild-type value  (number of ex- 
periments listed in Table I or Table II). (A) Mutants  of the invari- 
ant glycine in NBF1 ((;,551) or NBI"2 (G1349).  (B) Mutants  of the 
Walker consensus A lysine or consensus B aspartate  in the ATP- 
binding pocket of NBF1 (K464, D572) or NBF2 (K1250, D1370). 
that was ameliorated slightly by a smaller but significant 
stabilization  of this  state.  The  analogous  substitutions 
in NBF2 also reduced the on rate,  but only by 3- to 15- 
fold. Here also, the increase in KA was primarily due to 
reduced accessibility of the active state.  In either NBF, 
the  progressively less  conservative  substitutions  to ala- 
nine,  serine,  and  aspartic  acid  induced  significantly 
greater attenuations  of the on rate. 
Comparisons of the deactivation rates for glycine-sub- 
stituted  mutants  (Table  I)  revealed  differential  effects 
on the stability of the active state  that were not appar- 
ent in the calculated values of kof~.. Representative  time 
courses  for  deactivation  of NBF1  and  NBF2  mutants 
are  shown  in  Fig.  6  A,  and values  for the  latency and 
*k,,~ are compared in Fig. 7 A. Substitutions  tor the in- 
variant glycine in NBF2 (G1349) severely compromised 
the stability of the active state. Here, even the most con- 
servative  replacement  (G1349A)  dramatically  short- 
ened the latency and significantly increased the rate of 
exponential  decline.  This  destabilization  of  the  acti- 
vated state  is clearly evident in the representative  time 
courses  for  deactivation  of the  mutants  G1349S  and 
G1349D (Fig. 5 A). 
The effects of substitutions  for the  invariant  glycine 
in  NBF1  (G551)  on  deactivation  were  generally  less 
substantial.  The  most  conservative  substitution 
(G551A) did not appreciably alter the latency. The less 
conservative  substitutions  (G551S,  G551D)  progres- 
sively decreased the latency, but the reductions were al- 
ways less than those induced by the corresponding mu- 
tations  (G1349S,  G1349D)  in  NBF2.  The  progressive 
destabilization  of the  active state  suggested  by the  de- 
creased latency seen with the G551S and G551D substi- 
tutions  was  not  evident,  however,  in  the  subsequent 
phase  of exponential  decline.  The values  of *k,~ were 
similar to that for wild-type CFTR. 
Rate Analysis of A TP-Binding Pocket Mutants 
The rates of approach to steady state activation for mu- 
tants  of the  putative  ATP-binding  pockets  confirmed 
the impression  that both NBF1 and NBF2 are involved 
in gaining access to the active state and suggested that 
NBF2 is particularly important for determining the sta- 
bility  of  the  active  state.  The  representative  time 
courses  in  Fig.  4  B  show  that  substitutions  for  the 
Walker  consensus  A  lysine  in  either  NBF  produced 
comparable  reductions  in  the  relaxation  rate  (ko,  + 
ko~r). As shown in Table II, substitutions for the lysine in 
NBF1  (K464)  reduced  the  relaxation  rate  (ko,,  +  k~,f~) 
and increased  K  A (koff/k',m),  so the  decrease  in the  re- 
laxation rate was due to a  decrease in the on rate.  The 
effects of the alanine, glutamine, and arginine substitu- 
tions  were  similar,  resulting  in  66-83%  decreases  in 
k'o,. Although significant,  these reductions were some- 
what less than  those seen with the substitutions for the 
invariant  glycine  in  NBF1  (G551).  The  calculated  val- 
ues of k,,~. for K464Q and K464A indicated that the sub- 
stitutions  to alanine or glutamine also increased the off 
rate under activating conditions, which contributed  to 
the increase  in Ka and compensated somewhat for the 
reduction  in relaxation  rate caused by the reduced on 
rate. In contrast, the more conservative arginine substi- 
tution actually appeared to cause a modest stabilization 
of the active state. 
The comparable substitutions  for the lysine in NBF2 
(K1250)  produced relaxation  rates that were generally 
similar to those seen with their NBF1 counterparts,  be- 
cause of similar reductions in the on rate  (k',m). In ad- 
dition,  however,  substitutions  at  this  site  produced  a 
profound reduction in the apparent korr. Although this 
additional  reduction  in  the  off rate  was  not  immedi- 
ately apparent  in  the  relaxation  rates  (ko,  +  k,,~O be- 
cause  of the proportionately small  contribution  of the 
off rate, this apparent stabilization of the active state ac- 
counts for the values of K  A that were from 3.8- to 9-fold 
smaller  than  that for wild-type CFTR,  rendering  these 
mutants hypersensitive to activating conditions. 
The  substitution  of asparagine  for  the  Walker  con- 
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FIGURE 6.  Representative  time  courses  for 
deactivation  of CFTR  mutants  with  substitu- 
tions of analogous amino acids in NBF1 (solid 
￿9  ymb0/s) and NBF2 (open symbols). Designations 
are the same as those in Fig. 4. The representa- 
tive time course for wild-type CFTR (Fig. 2) is 
replotted  in  each  panel  for reference  (solid 
line).  Note the different time scales. (A)  Mu- 
tants of the invariant glycines. (B) Mutants  of 
the Walker consensus A lysines. (C) Mutants of 
the Walker consensus B aspartic acids. 
sensus  B  aspartic  acid  in  NBF1  (D572N)  produced  a 
profound  reduction  in  the  rate  of approach  to steady 
state  activation  (Fig. 4  C); the value  of (kon +  kof0 was 
comparable  with  that  seen  with  the  G551A  mutation 
(cf. Tables  I  and II). Although  the calculated  parame- 
ters are less reliable because of the relatively high value 
of the  apparent  KA,  the  value  of the  apparent  k'nn is 
consistent with a  marked  reduction  in the accessibility 
of the active state whereas the apparent off rate was not 
different from that of wild-type CFTR. In contrast,  the 
analogous  substitution  in  NBF2  (D1370N)  produced 
only a  modest decrease in  (ko,  +  kor0, evident in Fig. 4 
C. The values of the  derived  parameters  (k'o,,  ko~)  for 
this  slightly  hypersensitive  mutant,  however,  suggest 
that the decrease in K  A was a reflection of a fourfold de- 
crease in ko~, whereas the apparent  kon was not signifi- 
cantly different from that of wild-type CFTR. 
Values of the calculated  ko~ for CFTRs bearing muta- 
tions  in  the  putative  nucleotide  binding  pocket  of 
NBF1  or NBF2 suggested  that these  two domains  play 
different roles as regards the stability of the active state. 
This dichotomy was also evident in the deactivation pa- 
rameters that were measured directly (Fig. 5, B and C). 
In  NBF1,  substitutions  for  the  consensus  A  lysine 
(K464)  or  the  consensus  B  aspartic  acid  (D572)  de- 
creased the latency to 15-32% of the value for wild-type 
CFTR and significantly increased the measured off rate 
(*kon-), indicating destabilization  of the active state  (Ta- 
ble  II, Fig.  7).  In contrast,  substitutions  at  the  analo- 
gous sites in NBF2 (K1250 or D1370) actually increased 
the  latency by two- to  threefold,  and,  with  the  excep- 
tion of the most conservative substitution,  K1250R, the 
values  of *koff were  decreased  compared  with  that  of 
wild-type  CFTR,  indicating  stabilization  of the  active 
state.  These results suggest that the consensus A  lysine 
and  consensus  B  aspartic  acid  in  the  ATP  binding 
pocket of NBF1 contribute  to stabilization of the active 
state, whereas their analogues in NBF2 are involved in 
terminating  the active state.  Particularly noteworthy in 
this  regard  is  the  D1370N  mutation,  which  produced 
no significant effect on the apparent on rate but mark- 
edly delayed deactivation. 
In NBF2, the effects of substitutions at sites in the pu- 
tative ATP-binding pocket (K1250 and D1370) on deac- 
tivation were clearly opposite  to the effects of substitu- 
tions  for  the  invariant  glycine  (G1349).  The  former 
markedly  delayed  deactivation,  as  reflected  in  the  in- 
creased  latency and decreased  *ko~, whereas  the latter 
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FIGURE 7.  Summary of mutation-induced effects on the deactiva- 
tion parameters. The latency is the time elapsed between removal 
of the activating stimulus (time 0) and deactivation of gel to 85% of 
gcl(max), and *kofr is the measured rate coefficient for the subse- 
quent exponential phase  of deactivation.  Plotted values are  the 
means +  SEM for the ratios of the mutant values to the mean wild- 
type value (number of experiments listed in Table I or Table II). A 
and B are the same as Fig. 6. 
markedly  hastened  deactivation,  as  signaled  by the  re- 
duced  latency and  increased  *kotf (cf. Figs.  5  and  7). In 
NBF1,  mutations  at  sites  in  the  ATP  binding  pocket 
(K464  and  D572)  also  produced  effects  that  were  dif- 
ferent  from  those  of substitutions  for the  invariant  gly- 
cine  (G551).  Here,  however,  mutations  in the binding 
pocket  clearly hastened  deactivation,  evidenced  by de- 
creases  in  the  latency  and  increases  in  *kom  while  the 
mutations  of  glycine  551  moderately  decreased  *kom 
The  latency was also decreased  progressively by the less 
conservative mutations,  G551S and  G551D. 
In  general,  the  effects  of  mutations  on  the  latency 
were  mirrored  by those  on  the value  of *kom although 
the  latter  were  often  less  marked.  For  example,  the 
NBF2  glycine  mutants  exhibited  increased  values  of 
*kot  ~ in  conjunction  with  the  decreased  latency,  as  did 
the mutants  of the NBF1  binding  pocket.  Similarly, the 
value of *ko~was reduced  for most of the NBF2 binding 
pocket  mutants,  which  also  exhibited  increased  laten- 
cies.  There  were  exceptions  to  this  pattern,  however. 
For mutants  of the NBF1  glycine  (G551S  and  G551D), 
the values of *kon. did  not  increase  in conjunction  with 
the progressively decreased  latency. Similarly, although 
the  K1250R  and  D1370N  mutants  exhibited  an  in- 
creased  latency, the values of *ko~ were not significantly 
different  from  that of wild type CFTR. 
DISCUSSION 
Analyzing  the  functional  properties  of CF-fRs  bearing 
mutations  in the nucleotide  binding  domains  is one ap- 
proach  to  testing hypotheses  for the  roles of these  do- 
mains  in  activation  and  deactivation.  Our  analysis  fo- 
cused  on  analogous  residues  in  two  regions  of  each 
NBF: an invariant glycine  (G551  or G1349)  that is a  sig- 
nal  feature  of the  traffic  ATPase  superfamily  and  two 
other  residues,  the  invariant  Walker  A  lysine  (K464  or 
K1250)  and  the  highly  conserved  Walker  B  aspartic 
acid  (D572 or D1370),  which  are likely to lie within the 
hydrolytic core  of the ATP-binding  pocket.  The  results 
indicate  that  NBF1  and  NBF2  play distincdy  different, 
TABLE  II 
Summary of  Activation  and Deactivation of Wild-type CFTR and Mutants of the Walker Consensus A Lysine or Consensus B Aspartic Acid 
in the ATP Binding Pocket of NBF1 (K464, D572) or NBF2 (K1250, D1370) 
Activation  Deactivation 
kron 
K  A  (ko. + kott)  (10 -3 min  -l  kon  kofr  latency  *k~m 
CFTR  (mM)  n  (10-3 min  -])  mM  -1)  (10-3 min  1)  (10-3min-l)  n  (min)  (10  3min  i)  n 
wt  0.65 •  0.08  26  664 •  51  118 •  9  558 •  45  76 -+ 6  20  6.0 •  0.3  88 •  6  16 
K464R  2.6 •  0.1":  4  153 + 20**+  20 •  3***  101 •  13''`  52 •  7*:  5  1.3 •  0.2 *++  174 •  14"**  7 
K464Q  3.3 •  0.5"*  5  331 •  56***  40 -+ 7*  199 •  34*  132 •  22*'`  5  1.9 •  0.3"I  142 -+ 19''`  5 
K464A  4.6 •  0.7**  6  289 •  49*  30 •  5**  151 •  26***  139 •  24*:  7  1.1 •  0.1"**  133 •  14"**  8 
D572N  9.3 + 0.02*:  6  106 •  7*:  7 -+ 0.5*:  37 -+ 3***  69 •  5+*  4  0.9 •  0.2***  245 •  32*:  3 
K1250R  0.17 •  0.07*:  5  239 •  33***  46 -+ 6"+*  231 •  32*:  8 •  1":  10  10.4 •  0.8"~  100 •  7**  6 
K1250Q  0.12 •  0.04***  5  150 •  18''`  29 •  4*  146 -+ 18"  4 + 0.4"I  5  22.3 •  2.4*:  30 •  5":  5 
K1250A  0.07 + 0.02*:  10  218 •  18"  43 •  4*'`  215 •  18":  3 -+ 0.3 *~*  5  15.6 -+ 1.0"**  43 -+ 5**  5 
D1370N  0.16 + 0.04*'`  7  449 -  79*:  87 •  15:  435 + 76**  14 -  2*:  5  16.3 -4- 1.2""  69 -+ 6**  5 
The symbols (*) and ('`) indicate significant differences from wild-type CFTR and the analogous mutant, respectively (P <  0.05). 
112  CFFR Activation: Roles of NBF1 and NBF2 although overlapping, roles in the cycle of CFTR activa- 
tion and deactivation. Both NBF1 and NBF2 are impor- 
tant for accessing the activated state, but the results of 
rate analysis suggest a  dominant role for NBF1  in this 
process. Similarly, both NBFs influence the stability of 
the active state, but in different ways. Mutations in the 
ATP-binding  pocket  of NBF1  destabilized  the  active 
state, whereas the analogous mutations in NBF2 stabi- 
lized the active state, suggesting that NBF2 plays a ma- 
jor  role  in  regulating  the  termination  of the  active 
state.  The  effects  of mutations  in  the  ATP  binding 
pockets speak in favor of a  role for ATP hydrolysis in 
the  activities of both NBFs but suggest  that at NBF1, 
ATP  hydrolysis  is  associated  with  activating  CFTR, 
whereas at NBF2, ATP hydrolysis provides a mechanism 
for timing the duration of the active state. Finally, the 
results  suggest  that  within  each  NBF,  the  functional 
role  of the  invariant  glycine  (G551  or G1349)  is  dis- 
tinctly different from those of either the lysine  (K464 
or K1250) or the aspartic acid (D572 or D1370)  in the 
ATP-binding pocket. 
NBFI : Activation and Stabilization 
The results of rate analysis suggest that ATP-dependent 
processes  involving  NBF1  are  critical  for  activating 
CFFR C1-  channels and for maintaining the channels 
in the active state. This conclusion is based on the ob- 
servation  that  substitutions  in  NBF1  profoundly  af- 
fected both the accessibility and the stability of the ac- 
tive  state.  Substitutions  for  the  invariant  glycine 
(G551), the consensus A lysine (K464), or the consen- 
sus  B  aspartic  acid  (D572)  reduced  the  value  of k'on 
(Fig. 6). In addition, the effects on the latency parame- 
ter suggest that the substitutions in either the consen- 
sus A  or B regions of NBF1  markedly destabilized the 
active  state.  These  findings  are  consistent  with  a 
scheme in which ATP hydrolysis at NBF1 is the crucial 
event in ATP-dependent activation and the active state 
is stabilized by some product of ATP hydrolysis. 
A role for ATP hydrolysis at NBF1 in the activation of 
CFI'R is supported by functional evidence from other 
laboratories. Using detached membrane patches from 
transfected  NIH-3T3  fibroblasts,  Anderson  et  al. 
(1991a) showed that after exposure to a phosphorylat- 
ing  environment,  CFTR  CI-  channels  were  activated 
only in the presence of hydrolyzable ATP analogues, an 
observation  subsequently  confirmed  in  detached 
patches  from  transfected  HeLa  cells  (Carson  and 
Welsh,  1993), in guinea pig cardiac myocytes (Hwang 
et al., 1994), in lipid bilayers after fusion of membrane 
vesicles  from  transfected  HEK 293  cells  (Gunderson 
and Kopito, 1994), and in detached patches from trans- 
fected mouse L  cells  (Schultz et al.,  1995). Phosphate 
analogues such as orthovanadate and beryllium trifluo- 
ride prolonged the opening of CFTR C1- channels, but 
only after they had been opened by ATP (Baukrowitz et 
al., 1994; Gunderson and Kopito, 1994). These effects 
were not definitively localized to NBF1  but are consis- 
tent with the notions that ATP hydrolysis is required for 
activation and  that phosphate  analogues  stabilize  the 
active state of CFTR by slowing the dissociation rate of 
the hydrolysis product, ADP. Thus, mutations in NBF1 
that compromise either ATP binding or hydrolysis, or 
the  coupling  of  these  events  to  the  channel-gating 
mechanism,  would be predicted  to slow activation, as 
seen with  all  of the  NBF1  mutations  examined here. 
Furthermore, mutations that reduce the affinity for the 
hydrolysis product ADP would be predicted to destabi- 
lize the active state, as seen here with mutations of the 
consensus A lysine or the consensus B aspartic acid in 
NBF1. 
NBF2: Activation and Termination 
A striking result of the mutational analysis was the find- 
ing  that  substitutions  for  the  consensus  A  lysine 
(K1250)  or the  consensus  B  aspartic  acid  (D1370)  in 
the putative ATP-binding pocket of NBF2 dramatically 
stabilized the active state of CFFR. These findings sug- 
gest that an interaction of ATP at NBF2 regulates the 
duration  of the  active state.  This notion is  consistent 
with  the  observations  of  Hwang  et  al.  (1994),  who 
showed that the nonhydrolyzable ATP analogue, AMP- 
PNP, could stabilize the open state of cardiac CFTR C1- 
channels previously opened by exposure to ATP. The 
interdependence of the actions of ATP and AMP-PNP 
was interpreted as an indication that after the binding 
or hydrolysis of ATP  at  one  NBF  (NBDA),  AMP-PNP 
could bind at a second site (NBDB). The stabilizing ef- 
fect of AMP-PNP on CFTR gating,  also demonstrated 
by Gunderson and Kopito (1994), was interpreted as an 
indication  that  the  rate  of ATP  hydrolysis  at  NBDB 
times the duration of the active state. As discussed be- 
low, structural and functional studies of other ATPase 
proteins support the idea that substitutions for the con- 
sensus A lysine or the consensus B aspartate in the ATP- 
binding pocket would be likely to alter the rate of ATP 
hydrolysis.  The  rate  analysis  of  CFTR  mutants  pre- 
sented here is consistent with the notion that the NBDB 
of Hwang et al.  (1994)  is, in fact, NBF2 and that ATP- 
dependent processes at this site regulate  the  termina- 
tion of the active state. In a recent report, Gunderson 
and Kopito (1995) presented evidence for a cyclic gat- 
ing scheme for CFI'R comprising at least one  closed 
and two distinct open states, Oa and 02, that were dis- 
tinguished by a small difference in single-channel con- 
ductance. They proposed that ATP hydrolysis at NBF2 
can regulate the stability of the open state of CFTR by 
controlling the transition from the more stable Oa state 
to the less stable 02 state. 
The results from different laboratories regarding the 
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ATP-dependent gating of CFTR are not entirely consis- 
tent.  Carson  et al.  (1995)  studied  CFTR gating in de- 
tached  patches  from  stably  transfected  C127  mouse 
mammary cells.  Exposure of wild-type CFTR to AMP- 
PNP prompted the appearance of a distinct population 
of longer openings,  but these made  a  relatively small 
contribution to the open probability. Furthermore, in 
detached  patches  from  mouse  L  cells,  Schultz  et  al. 
(1995)  found  no  effect of AMP-PNP  on  either open 
probability or the  efficacy of ATP.  The  discrepancies 
between these results and those reported by Hwang et 
al.  (1994)  and Gunderson and Kopito (1994)  could be 
related  to  the  phosphorylation  state  achieved  in  de- 
tached patches or to other, as yet unresolved, method- 
ologic differences. Schultz et al.  (1995) called attention 
to a  possible role for temperature in determining the 
gating  kinetics  of CFTR.  Reducing  the  temperature 
from 35 to 25~  increased the open probability in mul- 
tichannel patches to near unity, and this effect was ob- 
served only in  the  presence  of PKA,  despite  the  fact 
that the enzyme was  not required to maintain  activity 
with a lower open probability. Those results suggested 
that  temperature,  in  addition  to  the  phosphorylation 
state, is important for determining the gating state of 
CFTR.  The  present  experiments  were  conducted  at 
temperatures ranging between  19 and 21~  and indi- 
cate clearly that in the intact oocyte maximally stimu- 
lated  by forskolin  and  IBMX,  mutations  in  NBF2  of 
CFTR can lead to a profound stabilization of the active 
state. Thus, in the oocyte, although CFTR gating may 
be slowed, it seems unlikely that this temperature, per 
se, increases Po to near unity. 
Structural  alterations  in  NBF2  also  significantly 
slowed the activation of CFTR. Thus, although the mu- 
tation analysis assigns to NBF2 a primary role in timing 
the active state,  this domain is also clearly involved in 
accessing the active state. There are at least two ways in 
which NBF2 could function in the activation of CFTR. 
ATP-dependent events at NBF2 could contribute to the 
conformational  changes  that  underlie  channel  open- 
ing in a manner that is independent of NBF1, or NBF2 
could act by modulating or otherwise contributing to 
events at NBF1. The latter view was proposed by Bauk- 
rowitz et al.  (1994)  as a  mechanism for the stabilizing 
effect of NBF2. Of particular interest in this regard was 
the effect of the NBF2 mutation, D1370N. This substi- 
tution  increased  the  stability  of the  active  state  but 
failed to significantly alter the on rate. This dichotomy 
suggests that it is possible to interfere with the timing 
function of NBF2 without affecting its role in accessing 
the  active state.  If it is  assumed  that  this  substitution 
acts by reducing the rate of ATP hydrolysis but not ATP 
binding, then the results imply that the binding of ATP 
at NBF2 is sufficient for its participation in activation. 
In this view, ATP hydrolysis at NBF1  drives the confor- 
mation  change  that  activates  the  channel,  and  NBF2 
participates  in  activation  as  a  modulator  of events  at 
NBF1. 
Roles of the Consensus A Lysine and Consensus B 
Aspartic Acid 
Structural  studies  of ATPase  proteins  offer some  in- 
sights into the possible functional roles of the A and B 
consensus regions in NBF1  and NBF2 of CFTR. These 
regions form portions  of the ATP-binding pockets  in 
ATPase  proteins  with  otherwise  diverse  primary  se- 
quences and functions. The consensus A motif, which 
forms a  phosphate-binding loop  (P-loop)  common to 
both  ATPase  and  GTPase  proteins  (Saraste  et  al., 
1990), is identified by the amino acid sequence G-X-X- 
G-X-G-K-T/S, in which the bold glycines (G) and lysine 
(K)  are invariant  (Walker et al.,  1982; Fry et al.,  1986; 
Hyde  et  al.,  1990;  Mimura  et  al.,  1991).  The  crystal 
structures of several ATPases  and  GTPases,  including 
the  FrATPase  (Abrahams  et  al.,  1994),  adenylate  ki- 
nase  (Mfiller  and  Schulz,  1992),  the  recA  protein 
(Story and Steitz, 1992), and the G-protein Gi0q  (Cole- 
man  et al.,  1994),  indicate  that  this  glycine-rich loop 
spans  the  hydrolytic core  of the  binding  pocket and 
that  the  invariant  lysine interacts directly with  the  [3- 
and ~/-phosphate groups of bound ATP, implying roles 
for this  lysine  in  both  the  binding  and  hydrolysis of 
ATP. Mutations  of this  lysine to arginine  in  the yeast 
RAD3 protein (Sung et al.,  1988), to alanine in the Es- 
cherichia  coli  UvrA  protein  (Thiagalingam  and  Gross- 
man,  1991),  or  to  glutamine  in  the  E.  coli  FrATPase 
(Senior  et  al.,  1993)  impaired  ATPase  activity.  ATP 
binding was not affected by the alanine substitution hut 
was  reduced  by the  arginine  and  glutamine  substitu- 
tions, although these reductions were less marked than 
the reductions in ATPase activity. 
The common location and apparently conserved role 
of the Walker consensus A lysine among ATPases and 
GTPases with diverse structures and functions suggest 
strongly that the analogous lysines in CFI'R are also lo- 
cated within the phosphate-binding, hydrolytic cores of 
the ATP-binding pockets in  NBF1  and  NBF2.  Hence, 
substitutions  for the  lysine in  NBF1  (K464)  or NBF2 
(K1250)  of CFTR would  be  expected  to  impair  both 
the binding and  subsequent hydrolysis of ATP by the 
NBF  bearing  the  mutation.  The  affinity  for  ADP  is 
likely to be reduced also, as the analogous lysines in the 
recA and ras proteins interact with the [3-phosphate of 
ADP  (Story  and  Steitz,  1992)  or  GDP  (Tong  et  al., 
1991). 
The Walker consensus B motif is identified generally 
by a stretch of four to six hydrophobic amino acids (h) 
followed by a  highly conserved aspartic  acid,  (h)4_6-D 
(Walker et al., 1982; Fry et al.,  1986; Hyde et al.,  1990; 
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tein  (Story  and  Steitz,  1992)  and  bovine  F1-ATPase 
(Abrahams et al., 1994) indicate that this aspartate also 
resides  within  the  phosphate  binding  portion  of the 
ATP-binding pocket. The position of this aspartate  in 
the recA protein suggested a role in coordinating Mg  2+ 
(Story and Steitz, 1992; Story et al., 1993). In contrast, 
no specific role was suggested by the position of this as- 
partate  in  F~-ATPase,  and  the  role  of  coordinating 
Mg  2+  was  assigned  to  a  threonine  adjacent  to  the 
Walker A lysine. Substitution of asparagine  (N) for this 
aspartate  in  phosphoglycerate  kinase  reduced  ATP 
binding  and  enzymatic activity  (Minard  et al.,  1990), 
and the equivalent substitution in E.  coli F~-ATPase re- 
duced  the  apparent  affinities  for  Mg  2+  and  Mg-ATP 
and diminished the maximum ATPase activity (Senior 
and Al-Shawi, 1992). Although the structural and func- 
tional  studies  of these  other  proteins  do  not  offer a 
completely coherent picture of the role of the Walker B 
aspartic  acid,  the  results  of the  rate  analysis  for  the 
CFTR  mutant  D1370N  are  consistent with  a  role  for 
this aspartic acid in ATP hydrolysis. 
Role of the Invariant Glycine 
The functional importance of the invariant glycine in 
NBF1  (G551) or NBF2 (G1349) is evident from the ex- 
istence  of mutations  (G551S,  G551D,  and  G1349D) 
that are associated with cystic fibrosis in humans  (Cut- 
ting et al., 1990; Kerem et al., 1990; Strong et al., 1991). 
However, unlike the residues in the consensus A and B 
motifs, which are found across families of ATPases and 
GTPases,  the  invariant glycine is  unique  to the traffic 
ATPase superfamily, for which crystal structures are not 
yet available.  It is  therefore more  difficult to  predict 
how this  residue  might  contribute  to ATP-dependent 
processes. One view, supported by structural modeling 
studies of a bacterial permease, His P, suggests that this 
glycine is part of a linker region that couples the ATP 
binding pocket to other parts of the protein  (Mimura 
et al., 1991; Shyamala et al., 1991 ), so substitutions might 
impair  the  transduction  of conformation  changes  in- 
duced by events in the binding pocket. Another view, 
suggested by structural  modeling of the multidrug re- 
sistance protein (Hyde et al., 1990), holds that this gly- 
cine is intimately associated with the binding pocket, so 
substitution might impact directly on the events of ATP 
binding and or hydrolysis. Support for the latter view is 
provided by the observation that the mutations G551D 
and  G1349D  impair  ATP  binding  in  isolated  fusion 
proteins of NBF1 and NBF2, respectively (Logan et al., 
1994). On the other hand, the results of Anderson and 
Welsh  (1992)  suggested that the mutations G551S and 
G1349D  reduced  the  open  probability  of CFTR  C1- 
channels  without  changing  the  K~/2 for the  effect of 
ATP concentration on open probability. 
The rate analysis does not pinpoint the function of 
the  invariant glycine, but  some  potentially important 
differences between effects of substitutions for the gly- 
cine and the consensus A and B residues are apparent. 
Most striking is the comparison of the effects of substi- 
tutions  in  NBF2  on  the  deactivation  parameters.  Re- 
placement of G1349, even by alanine, markedly destabi- 
lized the active state, indicated by a dramatic decrease in 
the latency. In contrast, substitutions for the consensus 
A  lysine  (K1250)  or  the  consensus  B  aspartic  acid 
(D1370)  stabilized the active state, as indicated by sub- 
stantial increases in the latency. In terms of the linker 
model, this dichotomy could suggest that G1349 is in- 
volved in transmitting conformation changes necessary 
for timing the duration of the active state but does not 
affect the rate of ATP hydrolysis at NBF2. Alternatively, 
this glycine could be positioned such that substitution 
would impair the access of ATP to the binding pocket 
but  not  the  hydrolysis  rate. Yet  another possibility is 
that substitution for this glycine actually increases the 
rate of ATP hydrolysis at NBF2. 
A similar dichotomy was seen in the effects of glycine 
and binding pocket mutations in NBFI. The most con- 
servative substitution for the glycine (G551A)  dramati- 
cally attenuated the on rate but tended to stabilize the 
active state.  Substitutions for the binding pocket resi- 
dues (K464 and D572) also slowed activation, but mark- 
edly destabilized  the  active  state.  If the  glycine func- 
tions as part of a  linker, then mutations that compro- 
mise entry into the active state could also make it more 
difficult to revert to the inactive conformation. On the 
other hand, if mutations of the glycine act by obstruct- 
ing the access of ATP to the binding pocket, this effect 
could also stabilize the ADP bound state somewhat. An 
increase in the rate of ATP hydrolysis as a result of gly- 
cine mutations  in NBF1  seems unlikely, as this would 
be predicted to increase the activation rate. 
Activation  and Block of CUFR by IBMX 
The goal of these studies was to examine the effects of 
mutations on the kinetics of transitions between the in- 
active and active states of the CFTR CI  channel. Ideally, 
this would be done by subjecting the channel to a step 
increase in the local concentration of the catalytic sub- 
unit  of protein  kinase A.  We  attempted  to  approach 
this ideal in oocytes by using the highest possible con- 
centration of IBMX  (5 mM)  to maximize the rate and 
extent of phosphodiesterase inhibition and, hence, the 
rate of activation of protein kinase A. In addition, con- 
centrations  of  IBMX  above  1  mM  are  required  to 
achieve significant activation of CFTR mutants such as 
G551D,  D572N,  and  G1349D  (cf.  Smit  et  al.,  1993). 
The use of 5 mM IBMX allowed us to compare insensi- 
tive, normal,  and  hypersensitive mutants  on the same 
basis.  The results indicate that mutations in the NBFs 
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vation  and  deactivation,  as expected if the  kinetics of 
the  macroscopic  cellular  response  are  dominated  by 
those reflecting transitions of the CFTR protein. 
The analysis of the results was complicated somewhat 
by the fact that 5 mM IBMX produced significant block 
of the activated CFTR conductance. This effect was par- 
ticularly  noticable  following  the  rapid  washout  of 
IBMX,  when  wild-type  CFTR  and  the  hypersensitive 
mutants exhibited a transient increase in gcl, consistent 
with rapid relief of IBMX block. The character of the 
deactivation  following  IBMX washout was  highly  mu- 
tant dependent, however, indicating that the dynamics 
reflected  the  effects of mutations  on  the  deactivation 
properties of CFFR. We confirmed this by using forsko- 
lin alone to activate CFTR. This is not a satisfactory pro- 
cedure  in  general  because  the  response  to  forskolin 
alone is absent for insensitive mutants and transient for 
normal and hypersensitive variants, perhaps because of 
vigorous phosphodiesterase activity in the oocytes (Sad- 
ler and Maller,  1987).  It was possible, however, to com- 
pare the deactivation of wild-type CFTR and hypersen- 
sitive mutants. After washout of 10 tzM forskolin, there 
was no transient increase in gc~, but the rate of decline 
was  Nfourfold  slower  for  the  hypersensitive  K1250A 
mutant, which is consistent with the results seen with 5 
mM IBMX. Similar results were obtained by activating 
with forskolin and 1 mM IBMX. These observations in- 
dicate  that the procedure  used here provides a  useful 
comparison of the dynamics of activation and deactiva- 
tion for CFTR mutants. 
Implications of Macroscopic Rates for Single-Channel Gating 
The  rate  of  approach  to  steady  state  activation  for 
CFTR-mediated C1- conductance was well described by 
a  single  exponential.  If the  gating  of CFTR channels 
were a two-state process, then the values for kon and ko~ 
derived from rate analysis would reflect the mean dwell 
times in the closed and open states of the channel,  re- 
spectively. Accordingly,  a  two-state  model  would  pre- 
dict mean closed  times of 1.7  rain  and  open  times of 
about 13 min for wild-type CFTR. Furthermore, the re- 
sults  presented  here would  predict that both  of these 
dwell times can be dramatically altered by mutations in 
the nucleotide binding folds. 
The gating of CFTR C1- channels has been studied in 
cell-attached and detached membrane patches from a 
variety of cell types expressing either native or recombi- 
nant  CFTR.  The  minimal  model  that  has  emerged 
from such  studies  would  comprise at least two closed 
states  and  one  open  state  (Haws  et al.,  1992;  Fischer 
and Machen, 1994; Venglarik et al., 1994; Winter et al., 
1994;  Schultz  et al.,  1995).  A  simple  C~ -~  C  ~  ~O 
model can account for the observation that, in an acti- 
vated  steady  state,  CFTR  gating  occurs  in  bursts  of 
rapid openings and closings separated by longer, inter- 
burst intervals. Furthermore, Carson et al.  (1995)  dem- 
onstrated  in detached  patches from transfected HeLa 
cells or 3T3 fibroblasts that the slow kinetics of steady 
state CFTR gating, i.e., burst length  and interburst in- 
terval, are altered by mutations in the NBFs, in a man- 
ner  that was,  in  part,  consistent  with  the  results  pre- 
sented  here.  For  example,  the  mutation  K1250A  in- 
creased the burst duration of CFTR by four- to fivefold, 
and  the analysis of CFTR deactivation in oocytes indi- 
cates that this substitution produced at least a threefold 
increase in the stability of the active state (Table II and 
Fig. 7). Similarly, the mutation K464A increased the in- 
terburst  interval  by fivefold,  whereas  rate  analysis  re- 
vealed a  nearly fourfold slowing of the  activation rate 
(k'o,1).  However,  the  open  probability of K1250A was 
decreased  by more  than  twofold,  largely because of a 
30-50-fold increase  in  the  interburst  interval,  an  effect 
that is not predicted by the present results. 
The parallels between the effects of mutations on the 
activation rate and the  single-channel  gating are strik- 
ing,  despite  the  great  disparity  in  the  characteristic 
times of these two processes. The values of burst length 
and interburst interval observed by Carson et al. (1995) 
would predict an activation time constant of about 100 
ms, whereas the time constant for activation of macro- 
scopic  C1-  conductance  in  oocytes  was  ~800-fold 
slower. This disparity could be, at least in part, a result 
of the substantial methodologic differences in the two 
studies. We studied the activation of CFTR by endoge- 
nous kinase in oocytes at room temperature (18-20~ 
whereas  Carson  et  al.  exposed  detached  membrane 
patches from mammalian cells to the catalytic subunit 
of protein  kinase  A  at  34-37~  In  general,  however, 
slower burst kinetics have been observed in on-cell re- 
cordings.  For  example,  when  CFTR  was  activated  in 
Calu-3 human airway cells at room temperature using 
forskolin  or  isoproterenol  (Haws  et  al.,  1994),  the 
mean interburst interval was 38.4 s and the mean open 
time was 1.8 s, which would predict a time constant for 
activation of 1.7 s. In oocytes activated using forskolin 
and  1 mM IBMX, Richards and Dawson  (unpublished 
observations)  observed  a  mean  interburst  interval  of 
~16 s and burst lengths of ~1 s, consistent with a time 
constant for activation of ~1 s. 
Despite the considerable variability in the kinetic pa- 
rameters, the available data suggest that the rates of ac- 
tivation and deactivation of CF-I'R in oocytes are domi- 
nated  by processes  that  are  much  slower  than  those 
which govern the durations of bursts and interburst in- 
tervals in the activated steady state. The sensitivity of ac- 
tivation and deactivation to NBF mutations implies that 
the  binding and  hydrolysis of ATP are important  ele- 
ments in these slow processes. As regards kinetic states, 
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state that precedes the bursting state, so that activation 
and  deactivation  rates  would  reflect  transitions  into 
and  out  of the  bursting  state.  Alternatively,  the  slow 
processes  could  represent  the  progression  through  a 
series of closed states, each of which is connected to an 
open state  that is more accessible or more stable than 
the one preceding. 
Some  support  for  the  notion  of a  time-dependent 
change in burst kinetics can be found in the  observa- 
tions of Fischer and Machen  (1994),  who studied  the 
time course for activation of wild-type CFTR channels 
in  NIH  3T3  fibroblasts  after  exposure  to  forskolin. 
They found that the open probability increased with a 
time constant of ~1  min,  similar  to that observed for 
the macroscopic conductance in oocytes. The increase 
in Po was primarily due to a decrease in the duration of 
a long closed state over this period. Preliminary obser- 
vations suggest that a similar process occurs in oocytes; 
that  is,  after  exposure  to  forskolin  and  IBMX,  open 
times increase and interburst intervals decrease with a 
time course of minutes. 
A minimal model for CFTR activation requires phos- 
phorylation of one or more sites on the R domain and 
the binding and hydrolysis of  ATP at one or both of the 
nucleotide  binding  folds.  The  apparent  slow  step  in 
CFTR activation could reflect dynamics of changes that 
are initiated by the interaction of the phosphorylated R 
domain  and  the  NBFs.  Other  studies  have  suggested 
that different phosphorylation states of CFTR have dif- 
ferent gating properties. Hwang et al.  (1993), for exam- 
ple,  defined  two  different  phosphorylation  states  of 
CFFR,  based  on  sensitivity  to  phosphatase  inhibitors, 
and suggested that these two states exhibited differen- 
tial sensitivity to ATP. Fischer and Machen  (1994)  also 
identified high and low Po states of CFTR that were as- 
sociated with different levels of stimulation  by forsko- 
lin. Also, a number of studies  (Chang et al.,  1993; Rich 
et al.,  1993)  have indicated that graded differences in 
CFTR channel activity can be achieved by the deletion 
of phosphorylation sites in the R domain or by the per- 
manent  deposition  of negative  charge  at  these  sites. 
The kinetics of CFFR activation in oocytes may reflect 
the  time  dependence  of conformational changes that 
depend on the phosphorylation state of the R domain, 
which could act to control the gain of ATP-dependent 
gating processes.  The slow kinetics  might also  reflect 
the  dme course of the addition and removal of CFTR 
channels from the plasma membrane. 
Implications for Cystic Fibrosis 
The results presented here provide some additional in- 
sights  into  the  mechanism by which  CFTR mutations 
produce  disease.  The  conserved  glycines  in  NBF1 
(G551)  and NBF2 (G1349)  are both sites of mutations 
that  cause  either  mild  (G551S)  or  severe  (G551D, 
G1349D) cystic fibrosis (Smitet al.,  1993)  but have not 
been associated with protein processing defects such as 
those that characterize the AF508 mutation. The analy- 
sis of activation kinetics presented here strengthens the 
notion that defects in channel function can cause cystic 
fibrosis and indicates that the molecular basis for defec- 
tive function can lie both in the access to and the stabil- 
ity of the  activated state.  The  activation  of these  mu- 
tants, however, suggests that understanding the details 
of these mechanisms could provide the basis for the de- 
sign of pharmacologic therapies aimed at amelioration 
of the symptoms of cystic fibrosis. 
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